We told you so: How the persistence of
With two novel immunotherapies approved and many more in the pipeline, is it time to announce that a new treatment modality has emerged? A class of therapy that has long held promise for treating cancer [more]
With two novel immunotherapies approved and many more in the pipeline, is it time to announce that a new treatment modality has emerged? A class of therapy that has long held promise for treating cancer [more]
Social and economic progress over the course of the last century has helped people in many countries enjoy longer, healthier lives. Public health, by and large, has improved and health interventions are now available to [more]
The Best Cancer Reporter Award 2006, sponsored by the European School of Oncology, has gone to Sarah Boseley, health reporter for the UK’s Guardian newspaper. She was commended for her thorough, balanced, informed and articulate’ [more]
A number of cancer vaccines are now entering the final stage of clinical development. Are vaccines finally on their way to enjoying mainstream success in the oncology arena? Download full article
Vaccines have long been seen as a potentially attractive option for treating cancer. Now a group targeting a peptide that plays a key role in CML think they may be onto a winner. Download full [more]